Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer
Open Access
- 20 August 2013
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 38 (7), 835-841
- https://doi.org/10.1111/apt.12446
Abstract
Background The role of a faecal immunochemical test (FIT) in screening individuals with a positive family history of colorectal cancer (CRC) is not clear. Aim To assess the diagnostic accuracy of FIT using colonoscopy findings as the gold standard in identifying colorectal neoplasms. Methods We analysed data from 4539 asymptomatic subjects aged 50–70 years who had both colonoscopy and FIT (Hemosure; W.H.P.M., Inc, El Monte, CA, USA) at our bowel cancer screening centre between 2008 and 2012. A total of 572 subjects (12.6%) had a family history of CRC. Our primary outcome was the sensitivity of FIT in detecting advanced neoplasms and cancers in subjects with a family history of CRC. A family history of CRC was defined as any first‐degree relative with a history of CRC. Results Among 572 subjects with a family history of CRC, adenoma, advanced neoplasm and cancer were found at screening colonoscopy in 29.4%, 6.5% and 0.7% individuals, respectively. The sensitivity of FIT in detecting adenoma, advanced neoplasm and cancer was 9.5% [95% confidence interval (CI), 5.7–15.3], 35.1% (95% CI, 20.7–52.6) and 25.0% (95% CI, 1.3–78.1), respectively. Among FIT‐negative subjects who have a family history of CRC, adenoma was found in 152 (29.6%), advanced neoplasm in 24 (4.7%) and cancer in 3 (0.6%) individuals. Conclusion Compared with colonoscopy, FIT is more likely to miss advanced neoplasms or cancers in individuals with a family history of CRC.This publication has 36 references indexed in Scilit:
- Increased Risk of Advanced Neoplasms Among Asymptomatic Siblings of Patients With Colorectal CancerGastroenterology, 2013
- Familial Colorectal Cancer Screening: So Close, So FarGastroenterology, 2013
- First-Degree Relatives of Colorectal Cancer Patients Are Likely to Show Advanced Colorectal Neoplasia despite a Negative Fecal Immunochemical TestDigestion, 2012
- Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trialThe Lancet, 2010
- Asia Pacific consensus recommendations for colorectal cancer screeningGut, 2008
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyGastroenterology, 2008
- Colonoscopy in Colorectal-Cancer Screening for Detection of Advanced NeoplasiaThe New England Journal of Medicine, 2006
- Relative and absolute risk of colorectal cancer for individuals with a family history: A meta-analysisEuropean Journal of Cancer, 2005
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996